We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Study Claims Additional Risks for Vioxx
New Study Claims Additional Risks for Vioxx
September 13, 2006
More trouble is emerging for Merck over its painkiller Vioxx, as researchers say they have found “increased renal and arrhythmia risks” from the drug and have confirmed cardiovascular risks.